CLEC5A and pancreatic adenocarcinoma: Moreover, our results found that high CLEC5A expression indicated poor OS and DFS in patients with THCA, LGG, PAAD, GBM, CESC, LICH, KIRC, and OV but predicted better OS and RFS in patients with SKCM, UCS, and KIRP.